AstroNova (ALOT) Q3 2025 earnings summary

Executive summary

• Q3 revenue increased 7.7% year-over-year to $40.4 million, driven by Test & Measurement (T&M) segment growth and the MTEX acquisition, but margins and profits declined due to MTEX integration challenges and higher costs.

• Net income for Q3 was $0.2 million ($0.03 per diluted share), down from $2.8 million ($0.37 per share) a year ago, impacted by MTEX-related costs.

• MTEX posted an operating loss of $1.1 million on $1.7 million in revenue, with initial sales volumes and margins below expectations.

• Cost reduction and product rationalization initiatives have been launched to address integration and margin pressures.

• The MTEX acquisition was completed in May 2024, expanding the PI segment but resulting in integration challenges and operating losses.

Financial highlights

• Gross profit margin fell to 33.9% from 39.4% year-over-year, with gross profit at $13.7 million, impacted by higher costs and lower MTEX margins.

• Operating expenses for Q3 increased to $12.5 million, mainly from MTEX-related costs.

• Adjusted EBITDA was $3.2 million, down from $5.7 million a year ago.

• Bookings were $37.6 million, up from $35.5 million; backlog was $27.1 million, down from $31.2 million year-over-year.

• Non-GAAP diluted EPS was $0.06, compared to $0.37 in Q3 last year.

Outlook and guidance

• No financial guidance for FY25 and FY26 due to the extended MTEX integration timeline; long-term targets to be shared in March.

• Full integration and optimization of MTEX operations expected to extend through mid-calendar 2025.

• Management expects PI segment revenue growth to turn positive in Q4 as delayed shipments resume and MTEX contributions continue.